HOME DEPARTMENTS SERVICES BLOG ADMINISTRATION WHO WE ARE CONTACTS 0965 756410 News MONDAY, SEPTEMBER 27, 2021 / COMMUNICATIONS Tuberculosis, a new, more effective vaccine is being studied To counter tuberculosis , new paths are being taken. Researchers from Purdue University and the Houston Methodist Research Institute have in fact completed a study that develops completely innovative intervention tools to develop an excellent vaccine for a rather common form of TB. In particular, the new formula discovered and used by scholars, the result of which was published in Cell Reports Medicine, would stimulate the immune system to an even more incisive and decisive reaction against tuberculosis caused by Mycobacterium. After the experimentation carried out through the nasal passages, the next step involves the application on primate models not belonging to humans and then move on to direct testing on our own species. L’obiettivo dei ricercatori è di creare un vaccino che sia più stabile ed efficace di quello attualmente impiegato con maggior frequenza, ovvero il Bcb (Bacillus Calmette-Guérin). Quest’ultimo, infatti, ha dimostrato un livello di azione scostante nei confronti della tubercolosi polmonare neonatale e adulta. La ricerca degli studiosi statunitensi giunge nel momento in cui l’attenzione dell’Unione Europea sulle misure terapeutiche di contrasto alla tubercolosi è molto alta. Non a caso il progetto quadro Horizon 2020 della Commissione ha stanziato 185 milioni di euro a tale scopo in una strategia di lungo periodo che vedrà impegnata una squadra di valenti ricercatori nei prossimi 7 anni. The entire initiative, which arises from the cooperation between public and private organizations united in a consortium, has been given the acronym UNITE4TB (Academia and industry united innovation and treatment for tuberculosis) and includes 30 partners from 13 countries worldwide. The ultimate goal is to move on to the third phase of the clinical trial. The protagonist of the work that will be carried out will also be the University of Milan. image source: https://www.pexels.com/ Discover all the SERVICES of the Caminiti Nursing Home Via Umberto I, 61 - 89018 - Villa San Giovanni (RC) 0965 756410 follow us on Facebook Follow us on Instagram Share! Facebook Twitter LinkedIn Whatsapp Messenger Share TAGGED IN: TBC , TUBERCULOSIS , TUBERCULOSIS VACCINE RECENT ARTICLES Glaucoma, an important new therapy in sight to block its causes HIV, AIFA approved the new monoclonal antibody for an innovative therapy Alzheimer's disease, the new discovery that opens up scenarios of great hope Rehabilitation robotics, a sector in progressive growth Parkinson's disease, the great efficacy of directional leads CATEGORIES General surgery Communications Hematology Digestive Endoscopy Useful Info Orthopedics and Traumatology CONTACTS You can contact the Caminiti Srl Nursing Home at the following numbers: Reception Tel. 0965 756410 Administration Fax 0965 751546 Via Umberto I, 61 - 89018 - Villa San Giovanni (RC) WHERE WE ARE CHARTER OF SERVICES The Caminiti Nursing Home makes its service card available to everyone, which can be downloaded and consulted in PDF format View Cookies and Privacy | VAT number 00674570809 | © 2018 all rights reserved Communication and web development MADES Srl We use cookies to offer you a better navigation on the Site. By continuing you accept the use of cookies and the privacy policy.I ACCEPTInfo